News

News publications

Jane ja Aatos Erkon säätiö myönsi lähes 10 miljoonaa euroa avustuksia

Tampereen yliopiston uutiset (2.10.2025)

Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders

Tampere University news (19.2.2025)

Tampere University, Theravia Partner to Advance New EB Drug

The Dermatology Digest

A new drug screening method could bring a solution to drug delivery and efficacy issues

EurekAlert! (26.2.2025)

Wound-homing molecule accelerates tissue repair

EurekAlert! (14.2.2025)

DecoDerma granted rare pediatric disease (RPD) designation for rare disease epidermolysis bullosa by the FDA

Tampere University news (10.11.2023)

DecoDerma granted orphan-drug designation for rare disease epidermolysis bullosa by FDA

Tampere University news (2.2.2023)

Chairman of the advisory board of DecoDerma awarded by The Albert Lasker prize

Tampere University news (29.9.2022)

The accompanying video interview is the 47th part of a series of interviews by the University of Tampere, Faculty of Medicine and Health Technology: “We are MET”. The episode was originally released on 18 August 2025.